Economic Update | September 2022
JPMorgan Chase Commercial Banking
From startups to legacy brands, you're making your mark. We're here to help.
As the summer season begins to wane, Ginger Chambless, Head of Research for JPMorgan Chase Commercial Banking, takes stock of the economic landscape today.?
If you’d like more insights like these, visit our Economic and Market Update page for Ginger’s weekly observations or to subscribe to her newsletter.
Economics and markets: Retail spending growth rises as gas prices retreat
Lower gasoline prices in July allowed for stronger spending elsewhere, notably online purchases. If inflation continues to retreat as we expect, sales in other categories could recover further.
Labor: Conditions remain tight yet payrolls start to resemble pre-pandemic levels
28 months after the pandemic onset and setbacks to the labor markets, we see a full recovery in payrolls. Demand for workers continues to exceed supply, with reduced participation and immigration patterns.
Inflation: Finally could be past peak, though some persistence ahead
While the drop in headline inflation to 8.5% in July was a relief, largely reflecting lower gas prices, the overall level is too high and the persistence of core inflation (services, rents) suggests no quick fix.
领英推荐
Supply chain: Clear signs of reduced pressure, but tensions remain
Supply chain pressures ease, with ocean freight costs down 33% from the beginning of the year and faster delivery times. This is likely due to moderating demand and relaxing of pandemic restrictions.
Interest rates: Set to rise further as inflation and jobs market still overheated
We expect another 125 basis points of hiking this cycle for a terminal fed funds rate range of 3.50-3.75%. This would be considered “restrictive,” as it’s above the estimated “neutral” funds rate of 2-2.5%.
Washington: The Inflation Reduction Act was signed into law on Aug. 16 by President Biden
The Act will provide government funding for climate change initiatives, healthcare subsidies and deficit reduction. Funding will come from tax provisions and prescription drug price reform.
? 2022 JPMorgan Chase & Co. All rights reserved.?JPMorgan Chase Bank, N.A. Member FDIC.?Chase, J.P. Morgan,?JPMorgan?and JPMorgan Chase are marketing names?for certain businesses of JPMorgan Chase & Co. and its subsidiaries worldwide (collectively, “JPMC”). The material contained herein is intended as general market commentary. To the extent indices have been used in this commentary, please note that it is not possible to invest directly in an index. The views, opinions, estimates and strategies, as the case may be (“views”), expressed herein are those of Virginia Chambless and/or the other respective authors and speakers named in this piece and may differ from those of other JPMC employees and affiliates. These views are often based on current market conditions and are subject to change without notice. Any examples used are generic, hypothetical and for illustration purposes only. This information in no way constitutes J.P. Morgan research and should not be treated as such. Further, the views expressed herein may differ from that contained in J.P. Morgan research reports. The above summary/prices/quotes/statistics have been obtained from sources deemed to be reliable, but we do not guarantee their accuracy or completeness.?Visit?jpmorgan.com/cb-disclaimer ?for full disclosures and disclaimers related to this content.